Italia markets closed

BMY Jan 2025 62.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
17,20+0,36 (+2,14%)
Alla chiusura: 11:11AM EDT
Schermo intero
Chiusura precedente16,84
Aperto17,70
Denaro17,50
Lettera18,65
Prezzo d'esercizio62,50
Scadenza2025-01-17
Min-Max giorno17,20 - 17,70
Contratto - Min-MaxN/D
Volume23
Open Interest1,05k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri